We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Mutations Lead to Retinitis Pigmentosa

By Biotechdaily staff writers
Posted on 28 Oct 2003
Researchers investigating the genetic linkages that determine the inheritance of retinitis pigmentosa have found two gene mutations that produce distinct retinitis pigmentosa phenotypes.

The investigators, at McGill University (Montreal, Canada), performed full ophthalmic evaluations and linkage analysis and then determined the likelihood of odds scores (LOD score) for 15 members of one French-Canadian family and for three members of a second family. More...
The two families had been afflicted with retinitis pigmentosa for four generations. Results were published in the October 2003 issue of the American Journal of Ophthalmology.

Two novel mutations were identified in the two families; a Glu 414 (2-bp del) frameshift mutation in the first family and an IVS 2–1 (g to a) splice site mutation in the second. These mutations resulted in variable, severe forms of the disease and in some cases other neurologic disorders, such as hearing loss.

"Our findings show that different gene mutations result in different symptoms of the disease,” explained senior author Dr. Guy Rouleau, a geneticist at McGill University. "Our study will provide hope to those families who have suffered from this disease for generations and will lead to new screening and diagnostic tests.”




Related Links:
McGill University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.